☆ 4.7 Article

Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination

NATURE REVIEWS IMMUNOLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Immunology

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada

Danuta M. Skowronski et al.

Summary: This study investigates the genetic diversity of influenza A(H3N2) viruses and the impact of vaccination history on vaccine effectiveness. The findings show heterogeneity in vaccine effectiveness and suggest that pivotal mutations and repeat vaccination using unchanged antigen may reduce vaccine effectiveness.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Editorial Material Medicine, General & Internal

A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose

Ruanne V. Barnabas et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment

A. David Paltiel et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply

Ashleigh R. Tuite et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Microbiology

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Allison J. Greaney et al.

Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.

CELL HOST & MICROBE (2021)

Add to Collection

Article Immunology

Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020

Mark W. Tenforde et al.

Summary: This study evaluated the effectiveness of the 2019-2020 influenza vaccine against influenza-associated hospitalization in the United States, showing a 41% reduction in risk of hospitalized influenza illness. Among the two major A(H1N1)pdmO9 subgroups, one subgroup had a vaccine effectiveness of 59%, while no effectiveness was observed in the other subgroup.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Infectious Diseases

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study

Fang Li et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Immunology

The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses

Paul D. Bieniasz

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang et al.

Summary: Volunteers who received the Moderna or Pfizer-BioNTech vaccine showed high levels of antibodies and memory B cell responses against SARS-CoV-2, with activity similar to individuals who had recovered from natural infection. However, their efficacy against specific SARS-CoV-2 variants was reduced, indicating a potential need for periodic updates to mRNA vaccines to maintain clinical efficacy.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 within-host diversity and transmission

Katrina A. Lythgoe et al.

Summary: The study found that SARS-CoV-2 infections in clinical samples in the UK are characterized by low levels of within-host diversity and a narrow bottleneck at transmission. Most variants are either lost or occasionally fixed at the point of transmission, with shared diversity not persisting.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes

Chadi M. Saad-Roy et al.

Summary: Given vaccine dose shortages and logistical challenges, various deployment strategies are being proposed to increase population immunity levels to SARS-CoV-2. While focusing on one dose may decrease infections in the short term, the long-term outcomes depend on the relative immune robustness of this approach. Under conditions of partial population immunity, a one-dose policy may increase the potential for antigenic evolution.

SCIENCE (2021)

Add to Collection

Article Microbiology

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck

Katarina M. Braun et al.

Summary: The evolution of SARS-CoV-2 in mammalian hosts is influenced by genetic variation and selection mechanisms. Using domestic cats as a model, it was found that within-host genetic variation is mainly driven by genetic drift and purifying selection, with transmission involving a narrow bottleneck. A notable variant in Spike (H655Y) was identified, showing rapid emergence and transmission, possibly under positive selection, underscoring the importance of continued genomic surveillance for emerging adaptations.

PLOS PATHOGENS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms

Sarah A. Clark et al.

Summary: The study reveals that mutations occurring during the evolution of SARS-CoV-2 virus may lead to resistance against antibodies, posing challenges to long-term efficacy.

CELL (2021)

Add to Collection

Letter Medicine, General & Internal

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Danuta M. Skowronski et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season

Brendan Flannery et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Temporal dynamics in viral shedding and transmissibility of COVID-19

Xi He et al.

NATURE MEDICINE (2020)

Add to Collection

Article Immunology

Reconstruction of Transmission Pairs for Novel Coronavirus Disease 2019 (COVID-19) in Mainland China: Estimation of Superspreading Events, Serial Interval, and Hazard of Infection

Xiao-Ke Xu et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Multidisciplinary Sciences

Potently neutralizing and protective human antibodies against SARS-CoV-2

Seth J. Zost et al.

NATURE (2020)

Add to Collection

Article Microbiology

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate

Amin Addetia et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Dillon C. Adam et al.

NATURE MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Biology

Asynchrony between virus diversity and antibody selection limits influenza virus evolution

Dylan H. Morris et al.

ELIFE (2020)

Add to Collection

Article Biology

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Yiska Weisblum et al.

ELIFE (2020)

Add to Collection

Article Immunology

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Norbert Pardi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Within-Host Evolution of Human Influenza Virus

Katherine S. Xue et al.

TRENDS IN MICROBIOLOGY (2018)

Add to Collection

Article Biology

Stochastic processes constrain the within and between host evolution of influenza virus

John T. McCrone et al.

ELIFE (2018)

Add to Collection

Article Immunology

Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015

Mark G. Thompson et al.

VACCINE (2018)

Add to Collection

Article Virology

Estimating Vaccine-Driven Selection in Seasonal Influenza

Frank T. Wen et al.

VIRUSES-BASEL (2018)

Add to Collection

Article Microbiology

Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses

Kari Debbink et al.

PLOS PATHOGENS (2017)

Add to Collection

Article Biology

Parallel evolution of influenza across multiple spatiotemporal scales

Katherine S. Xue et al.

ELIFE (2017)

Add to Collection

Article Immunology

Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

Carmen Arriola et al.

CLINICAL INFECTIOUS DISEASES (2017)

Add to Collection

Article Immunology

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season

Danuta M. Skowronski et al.

CLINICAL INFECTIOUS DISEASES (2016)

Add to Collection

Article Medicine, General & Internal

Fractional dosing of yellow fever vaccine to extend supply: a modelling study

Joseph T. Wu et al.

LANCET (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Epistasis in protein evolution

Tyler N. Starr et al.

PROTEIN SCIENCE (2016)

Add to Collection

Article Immunology

Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012-2013 Season in the United States

Carmen S. Arriola et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

Add to Collection

Article Virology

Systematic Identification of H274Y Compensatory Mutations in Influenza A Virus Neuraminidase by High-Throughput Screening

Nicholas C. Wu et al.

JOURNAL OF VIROLOGY (2013)

Add to Collection

Article Biology

Stability-mediated epistasis constrains the evolution of an influenza protein

Lizhi Ian Gong et al.

ELIFE (2013)

Add to Collection

Article Multidisciplinary Sciences

Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance

Jesse D. Bloom et al.

SCIENCE (2010)

Add to Collection

Review Multidisciplinary Sciences

The fixation probability of beneficial mutations

Z. Patwa et al.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2008)

Add to Collection

Article Genetics & Heredity

Beneficial mutation-selection balance and the effect of linkage on positive selection

Michael M. Desai et al.

GENETICS (2007)

Add to Collection

Article Medicine, General & Internal

Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate

Steven Riley et al.

PLOS MEDICINE (2007)

Add to Collection

Article Biochemistry & Molecular Biology

The speed of evolution and maintenance of variation in asexual populations

Michael M. Desai et al.

CURRENT BIOLOGY (2007)

Add to Collection

Review Multidisciplinary Sciences

Unifying the epidemiological and evolutionary dynamics of pathogens

BT Grenfell et al.

SCIENCE (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.